Reviewed by MD. Catarina Costa, Internal Medicine · Medical Advisor at Octo HealthWe have spent thousands of hours across cognitive neuroscience research, clinical literature, and the gap between what standard care measures and what actually drives brain performance. This is the distilled version: the markers that actually matter, the context standard care never provides, and the evidence-backed changes the research consistently associates with sharper, more sustained mental performance.
Start here: three free things you can do today
- Delay your first caffeine 90 to 120 minutes after waking. It lets the cortisol awakening response complete, which research associates with a steadier afternoon and a smaller energy dip.
- Work in single-task blocks with notifications off. Task-switching has been quantified at roughly a 40% efficiency cost. Blocked focus preserves output that multitasking never can.
- Walk 10 to 15 minutes after meals. Postprandial glucose spikes, even within the normal range, are associated with impaired working memory and attention in the hours that follow.
A few minutes a day, at no cost. The full 90-day plan below turns these into a routine you can keep.
Source: Alzheimer's Association
Why this matters
Most people notice cognitive changes, slower recall, difficulty concentrating, that particular frustration of a word sitting just out of reach, and attribute them to stress, age, or screen time. The research points to something more specific: a set of modifiable biological variables that, when off, make the brain work harder for worse output.
Standard care does not measure most of them. A TSH is sometimes ordered. Vitamin D, occasionally. Homocysteine, almost never. Fasting insulin is not part of any standard cognitive workup. Research associates insulin resistance with Alzheimer's pathology through a framework researchers have called "type 3 diabetes", an associative framework supported by multiple observational and mechanistic studies, not an established causal diagnosis.
The markers that matter
HomocysteineOptimal below 7 mcmol/L · Standard below 15 mcmol/L (flagged only when markedly elevated)
In plain English. An amino acid that accumulates when B vitamin metabolism is impaired, a cerebrovascular and neurological risk marker.
Think of homocysteine as a metabolic waste product, like exhaust from an engine. When B vitamins are sufficient it gets converted and cleared. When they are not, it accumulates. Research associates chronic elevation with damage to blood vessel walls and, over decades, with increased risk of cognitive decline, an associative finding rather than an established causal relationship.
The gap between the two numbers is where most of the modifiable risk sits. A homocysteine of 11 mcmol/L passes every standard panel uncontested, and in the research on cognitive aging it is a signal worth addressing. A randomized controlled trial found B vitamin supplementation in subjects with elevated homocysteine was associated with a 53% reduction in the rate of brain atrophy over two years, one of the most striking intervention findings in cognitive aging research.
Homocysteine is one of those markers where the research is clear and clinical practice has not caught up. The correction is straightforward, B6, B12, folate, and yet it is absent from almost every standard preventive panel. It is not expensive to test. It is not difficult to treat. It is simply not ordered.
MD. Catarina Costa, Medical Advisor
Unlock the read
Enter your email and the rest is yours, free.
Your whole body, on one timeline.
Every lab, every wearable, every check-in, tracked over the years and read as a system.